Even if the conclusions of clinical studies performed only on HAB or MAB patients might be extended to a whole-patient population, at least in AD [69], this polymorphism makes more difficult the design of clinical trials based on TSPO PET imaging. The gene discussed is TSPO; the disease is Alzheimer disease.